A
Active Biotech AB publ
STO:ACTI
Active Biotech AB publ
STO:ACTI
Price:
0.074
SEK
3.5%
Market Closed
Market Cap:
kr195.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Common Stock
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Active Biotech AB publ
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Common Stock
kr13.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Common Stock
kr20.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Common Stock
kr41.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Common Stock
kr28m
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Common Stock
kr196m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
ACTI
Intrinsic Value
0.029
SEK
Overvaluation 61%
A
See Also
What is Active Biotech AB publ's Common Stock?
Common Stock
13.6m
SEK
13.6m
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Common Stock amounts to 13.6m SEK.
What is Active Biotech AB publ's Common Stock growth rate?
Common Stock CAGR 1Y
114%
114%
Over the last year, the Common Stock growth was 114%.
